A detailed history of Hexagon Capital Partners LLC transactions in Medtronic PLC stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,100 shares of MDT stock, worth $262,694. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,106 0.19%
Holding current value
$262,694
Previous $244,000 14.34%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$76.84 - $91.03 $461 - $546
-6 Reduced 0.19%
3,100 $279,000
Q2 2024

Jul 12, 2024

BUY
$78.71 - $87.02 $19,205 - $21,232
244 Added 8.53%
3,106 $244,000
Q1 2024

Apr 18, 2024

SELL
$82.84 - $88.09 $32,804 - $34,883
-396 Reduced 12.15%
2,862 $249,000
Q4 2023

Feb 05, 2024

BUY
$69.43 - $83.43 $31,660 - $38,044
456 Added 16.27%
3,258 $268,000
Q3 2023

Oct 23, 2023

SELL
$78.22 - $90.4 $17,912 - $20,701
-229 Reduced 7.56%
2,802 $219,000
Q2 2023

Jul 24, 2023

BUY
$79.47 - $91.38 $21,695 - $24,946
273 Added 9.9%
3,031 $267,000
Q1 2023

Apr 24, 2023

BUY
$76.72 - $87.58 $10,894 - $12,436
142 Added 5.43%
2,758 $222,000
Q4 2022

Jan 13, 2023

BUY
$76.18 - $87.74 $57,668 - $66,419
757 Added 40.72%
2,616 $0
Q3 2022

Oct 17, 2022

BUY
$80.75 - $95.31 $46,269 - $54,612
573 Added 44.56%
1,859 $150,000
Q2 2022

Jul 21, 2022

BUY
$87.4 - $113.09 $29,191 - $37,772
334 Added 35.08%
1,286 $115,000
Q1 2022

Apr 13, 2022

BUY
$100.58 - $112.38 $301 - $337
3 Added 0.32%
952 $106,000
Q4 2021

Jan 27, 2022

BUY
$99.53 - $127.75 $7,962 - $10,220
80 Added 9.21%
949 $98,000
Q3 2021

Nov 12, 2021

BUY
$122.75 - $135.17 $2,455 - $2,703
20 Added 2.36%
869 $109,000
Q1 2021

May 13, 2021

SELL
$111.18 - $119.74 $11,673 - $12,572
-105 Reduced 11.01%
849 $100,000
Q3 2020

Nov 10, 2020

BUY
$90.13 - $108.78 $85,984 - $103,776
954 New
954 $97,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.